IMMIX BIOPHARMA INC. - COMMON STOCK
2.4700
17-May-24 14:59:51
15 minutes delayed
Stocks
+0.2200
+9.78%
Today's range
2.2500 - 2.4746
ISIN
N/A
Source
NASDAQ
-
06 Nov 2023 07:40:00 By Nasdaq GlobeNewswire
-
Immix Biopharma Completes 3rd NXC-201 Engineering Batch at its U.S. CAR-T Manufacturing Site
16 Oct 2023 08:05:00 By Nasdaq GlobeNewswire
-
03 Oct 2023 08:14:00 By Nasdaq GlobeNewswire
-
02 Oct 2023 07:06:00 By Nasdaq GlobeNewswire
-
21 Sep 2023 07:55:00 By Nasdaq GlobeNewswire
-
19 Sep 2023 08:10:00 By Nasdaq GlobeNewswire
-
07 Sep 2023 07:41:00 By Nasdaq GlobeNewswire
-
23 Aug 2023 07:37:00 By Nasdaq GlobeNewswire
-
18 Aug 2023 08:20:00 By Nasdaq GlobeNewswire
-
25 Jul 2023 07:42:00 By Nasdaq GlobeNewswire
-
10 Jul 2023 08:47:00 By Nasdaq GlobeNewswire
-
Immix Biopharma Subsidiary Nexcella Completes Pre-IND Meeting with FDA on NXC-201 US Clinical Trial
26 Jun 2023 08:49:00 By Nasdaq GlobeNewswire
-
22 Jun 2023 08:53:00 By Nasdaq GlobeNewswire
-
20 Jun 2023 08:45:00 By Nasdaq GlobeNewswire
-
16 Jun 2023 08:43:00 By Nasdaq GlobeNewswire
-
Immix Biopharma Completes $5 Million At-The-Market Equity Offering Program
14 Jun 2023 06:30:00 By Nasdaq GlobeNewswire